Common-Size Balance Sheet: Assets
Quarterly Data
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., common-size consolidated balance sheet: assets (quarterly data)
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Cash and cash equivalents
- The proportion of cash and cash equivalents relative to total assets exhibits notable volatility across the periods. Starting at 14.01% in March 2020, it declined sharply to below 9% by March 2021. It then experienced periods of slight recovery and decline, reaching lows near 5-6% in mid-2024 and beyond. This trend suggests a reduction in readily available liquidity over time, with intermittent recoveries possibly indicating tactical cash management.
- Marketable securities
- The allocation to marketable securities as a percentage of total assets shows a significant upward trend over the analyzed periods. From 11.39% in March 2020, it increased markedly, peaking above 24% in late 2023 and remaining relatively high afterward, though with some fluctuation. This pattern indicates a strategic shift towards liquid, investable assets, potentially to optimize yield or maintain flexibility.
- Accounts receivable, net
- Accounts receivable percentages fluctuate considerably. Initially rising from approximately 18.6% to a peak of over 32% in mid-2021, it then declined steadily to around 14-16% during 2024 and 2025. The initial rise may reflect expanding sales or delayed collections, whereas the subsequent decline may be indicative of improved collection efficiency or a leveling of revenue growth.
- Inventories
- Inventory levels relative to total assets demonstrate moderate variability, ranging from a high near 12% in early 2021 to stable values around 8% in subsequent periods. The downward adjustment from 2021 suggests possible optimization of stock levels or changes in production and sales dynamics.
- Prepaid expenses and other current assets
- This category remains relatively stable, generally fluctuating between 1% and 2%, without notable sustained trends. Minor variability may result from seasonal operational changes or adjustments in expense recognition.
- Current assets
- The percentage composition of current assets in total assets shows a declining trend from 54.86% in March 2020 to levels around 44-46% in 2024 and 2025. This gradual decline, coupled with increases in certain noncurrent asset categories, suggests a portfolio rebalancing with increased investment in longer-term asset categories.
- Property, plant, and equipment, net
- Property, plant, and equipment relative to total assets decreases over the periods reviewed, from nearly 19% in early 2020 to roughly 12-13% by 2025. This reduction may indicate depreciation outpacing capital expenditures, asset disposals, or shifts in asset structure away from fixed assets.
- Intangible assets, net
- Intangible assets appear starting from late 2022 data, representing approximately 3% of total assets and showing a slight upward trend to around 3.5% by late 2025. This gradual increase suggests ongoing investments or capitalization in intangible resources such as patents, licenses, or goodwill.
- Deferred tax assets
- Deferred tax assets as a proportion of total assets show a clear upward trajectory from about 4.9% in early 2020 to over 9.5% by the end of the analyzed timeframe. This consistent growth may reflect increased timing differences, tax credit carryforwards, or recognition of future tax benefits associated with losses or expenses.
- Other noncurrent assets
- Other noncurrent assets remain a small but gradually increasing percentage of total assets, rising from near 1% in 2020 to over 4% by late 2025. The increase may indicate accumulation of miscellaneous asset categories such as long-term receivables, advances, or investments in affiliates.
- Noncurrent assets
- The overall composition of noncurrent assets relative to total assets fluctuates throughout the periods but generally trends upwards from around 43% in 2020 to over 55% by 2025. This shift confirms an increased emphasis on long-term investments, fixed assets, and intangible assets within the company’s asset base.
- Total assets
- As expected, total assets are normalized to 100% each period and serve as the baseline for the relative analysis of asset composition trends described above.